Journal
CANCER INVESTIGATION
Volume 34, Issue 4, Pages 189-196Publisher
TAYLOR & FRANCIS INC
DOI: 10.3109/07357907.2016.1166232
Keywords
Health sciences research; Outcomes research; Imaging
Categories
Funding
- National Cancer Institute [R25 CA09406, NCI R01 CA166084, NCI R01CA169121]
- Conquer Cancer Foundation of the American Society of Clinical Oncology
Ask authors/readers for more resources
Image-guided percutaneous liver biopsy (PLB) is a diagnostic tool for lesions in the liver. Hemorrhage is the most common complication. We selected patients with a diagnostic claim for cancer who had undergone PLB. There were a total of 26,941 patients who underwent PLB. Hemorrhage risk was 1.43% among patients undergoing PLB. When stratified by setting, odds of hemorrhage were 4.5times higher when biopsy was performed in an inpatient setting (p < .001). Risk factors associated with hemorrhage included marital status, liver cancer and comorbidity score. The use of PLB has increased over time. Reassuringly, the hemorrhage risk associated with PLB is low.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
